FIBROGEN INC — Director's Dealing 2023

Mar 11, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-03-08

Reporting Person: Wettig Thane (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-08	Common Stock	S	6265	$21.1559	Disposed	104090	Direct
2023-03-08	COmmon Stock	A	5799	$0.00	Acquired	109889	Direct
2023-03-08	Common Stock	A	9338	$0.00	Acquired	119227	Direct
2023-03-10	Common Stock	S	2938	$20.1973	Disposed	116289	Direct
2023-03-10	Common Stock	S	4731	$20.1973	Disposed	111558	Direct

Footnotes

F1: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.

F2: Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.

F3: Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.

F4: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.